GlassScriptPhysician profile
Christopher Andrew Hall
NPI 1013250265
$15,006.42
in general payments reported to CMS, 2019-2025
22 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $13K · 2021: $491 · 2022: $469 · 2023: $392 · 2024: $191 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679 · Travel and Lodging: $37.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.17 |
| Travel and Lodging | $37.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,966.64 | 2020-2025 | |
| Abbvie INC. | $642.31 | 2019-2023 | |
| Pfizer INC. | $296.82 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $200.00 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $191.59 | 2021-2025 | Aptima, Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $170.94 | 2022 | |
| Exeltis, USA INC. | $148.62 | 2021-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $77.20 | 2019-2022 | |
| Astellas Pharma US INC | $44.69 | 2024 | Veozah |
| Therapeuticsmd, INC. | $35.67 | 2019 | |
| Merck Sharp & Dohme LLC | $29.91 | 2019-2022 | |
| Daiichi Sankyo INC. | $26.84 | 2019 | |
| Medtronic, INC. | $23.34 | 2023 | Truclear |
| Organon LLC | $23.29 | 2022 | |
| Millicent US INC | $20.14 | 2025 | Femlyv, Intrarosa |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $19.61 | 2024 | Ultomiris |
| Horizon Therapeutics Plc | $15.49 | 2020 | |
| Alfasigma USA, INC. | $15.22 | 2021 | |
| Amag Pharmaceuticals, INC. | $15.19 | 2019 | |
| Ethicon US, LLC | $14.99 | 2024 | Echelon; Endopath |
| Allergan, INC. | $14.41 | 2019 | |
| Mayne Pharma Commercial LLC | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.